265 related articles for article (PubMed ID: 30111719)
1. Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs.
Liang D; Wu X; Hasinoff BB; Herbert DE; Tranmer GK
Molecules; 2018 Aug; 23(8):. PubMed ID: 30111719
[TBL] [Abstract][Full Text] [Related]
2. 10-Boronic acid substituted camptothecin as prodrug of SN-38.
Wang L; Xie S; Ma L; Chen Y; Lu W
Eur J Med Chem; 2016 Jun; 116():84-89. PubMed ID: 27060760
[TBL] [Abstract][Full Text] [Related]
3. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect.
Prada CF; Alvarez-Velilla R; Balaña-Fouce R; Prieto C; Calvo-Álvarez E; Escudero-Martínez JM; Requena JM; Ordóñez C; Desideri A; Pérez-Pertejo Y; Reguera RM
Biochem Pharmacol; 2013 May; 85(10):1433-40. PubMed ID: 23466420
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of 10-Substituted Camptothecin Derivatives with Improved Water Solubility and Activity.
Yang XY; Zhao HY; Lei H; Yuan B; Mao S; Xin M; Zhang SQ
ChemMedChem; 2021 Mar; 16(6):1000-1010. PubMed ID: 33241878
[TBL] [Abstract][Full Text] [Related]
5. Suzuki coupling based synthesis and in vitro cytotoxic evaluation of 7-heteroaryl-substituted camptothecin analogs.
Wang L; Huang Y; Zhang J; Tong L; Chen Y; Lu W; Huang Q
Bioorg Med Chem Lett; 2014 Mar; 24(6):1597-9. PubMed ID: 24529870
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation.
Prijovich ZM; Burnouf PA; Chou HC; Huang PT; Chen KC; Cheng TL; Leu YL; Roffler SR
Mol Pharm; 2016 Apr; 13(4):1242-50. PubMed ID: 26824303
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin-7-yl-methanthiole: semisynthesis and biological evaluation.
Christodoulou MS; Zunino F; Zuco V; Borrelli S; Comi D; Fontana G; Martinelli M; Lorens JB; Evensen L; Sironi M; Pieraccini S; Dalla Via L; Gia OM; Passarella D
ChemMedChem; 2012 Dec; 7(12):2134-43. PubMed ID: 23086693
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new homocamptothecin analogs.
Luo Y; Yu S; Tong L; Huang Q; Lu W; Chen Y
Eur J Med Chem; 2012 Aug; 54():281-6. PubMed ID: 22647222
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of hypoxia-activated prodrugs of SN-38.
Jin C; Zhang Q; Lu W
Eur J Med Chem; 2017 May; 132():135-141. PubMed ID: 28350997
[TBL] [Abstract][Full Text] [Related]
10. Programmed activation of cancer cell apoptosis: A tumor-targeted phototherapeutic topoisomerase I inhibitor.
Shin WS; Han J; Kumar R; Lee GG; Sessler JL; Kim JH; Kim JS
Sci Rep; 2016 Jul; 6():29018. PubMed ID: 27374023
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 9-(heteroarylmethylidene)amino derivatives of homocamptothecin with biological activities.
Guo W; Miao Z; Sheng C; Yao J; Liu W; Zhu L; Zhang Y; Cheng P; Dong G; Zhuang C; Zhang W
Chem Biodivers; 2011 Jul; 8(7):1266-73. PubMed ID: 21766447
[TBL] [Abstract][Full Text] [Related]
12. Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies.
Yoon KJ; Krull EJ; Morton CL; Bornmann WG; Lee RE; Potter PM; Danks MK
Mol Cancer Ther; 2003 Nov; 2(11):1171-81. PubMed ID: 14617791
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors.
Liu W; Zhu L; Guo W; Zhuang C; Zhang Y; Sheng C; Cheng P; Yao J; Wang W; Dong G; Wang S; Miao Z; Zhang W
Eur J Med Chem; 2011 Jun; 46(6):2408-14. PubMed ID: 21463912
[TBL] [Abstract][Full Text] [Related]
14. Bioreduction activated prodrugs of camptothecin: molecular design, synthesis, activation mechanism and hypoxia selective cytotoxicity.
Zhang Z; Tanabe K; Hatta H; Nishimoto S
Org Biomol Chem; 2005 May; 3(10):1905-10. PubMed ID: 15889173
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.
Uehling DE; Nanthakumar SS; Croom D; Emerson DL; Leitner PP; Luzzio MJ; McIntyre G; Morton B; Profeta S; Sisco J
J Med Chem; 1995 Mar; 38(7):1106-18. PubMed ID: 7707314
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I.
Guo W; Miao Z; Sheng C; Yao J; Feng H; Zhang W; Zhu L; Liu W; Cheng P; Zhang J; Che X; Wang W; Luo C; Xu Y
Eur J Med Chem; 2010 Jun; 45(6):2223-8. PubMed ID: 20202723
[TBL] [Abstract][Full Text] [Related]
17. A series of camptothecin prodrugs exhibit HDAC inhibition activity.
Zhu Q; Yu X; Shen Q; Zhang Q; Su M; Zhou Y; Li J; Chen Y; Lu W
Bioorg Med Chem; 2018 Sep; 26(16):4706-4715. PubMed ID: 30115492
[TBL] [Abstract][Full Text] [Related]
18. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity evaluation of a novel series of camptothecin analogs.
Lv J; Guo N; Wen SP; Teng YO; Ma MX; Yu P
J Asian Nat Prod Res; 2013; 15(8):867-74. PubMed ID: 23796391
[TBL] [Abstract][Full Text] [Related]
20. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
Leu YL; Chen CS; Wu YJ; Chern JW
J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]